Skip to main content

Table 1 Characteristics of Participating Patients: Non-Injectors and Injectors

From: Drug treatment program patients' hepatitis C virus (HCV) education needs and their use of available HCV education services

  Non-Injectors
(N = 121)
Injectors
(N = 159)
All Patients
(N = 280)
Female (%) 43.8 47.2 45.7
Hispanic (%)** 25.6 12.6 18.2
Race (%)***    
   Black 44.6 18.9 30.0
   White 36.4 66.0 53.2
   Other 19.0 15.1 16.8
Age (mean, s.d.)** 37.7 (10.3) 41.2 (10.2) 39.7 (10.4)
High School degree or above (%) 66.1 71.7 69.3
Married/Common Law (%)** 12.4 27.0 20.7
Most frequently used drugs in the 6 months before treatment (%)    
   Opiates*** 36.8 80.9 62.0
   Cocaine or crack 60.7 58.6 59.5
   Alcohol 53.0 42.7 47.1
Primary drug used in the 6 months before treatment (%) ***    
   Opiates 33.3 70.1 54.4
   Cocaine or crack 35.9 8.3 20.1
   Alcohol 16.2 6.4 10.6
   Other 14.5 15.3 15.0
Years since first used primary drug (mean, s.d.)** 17.5 (10.6) 21.2 (11.2) 19.6 (11.0)
Used primary drug every day in 6 mos. before treatment (%)*** 70.1 86.6 79.6
In drug treatment before this time (%)*** 52.1 73.6 64.3
   - Of these, times in drug tx. in the past (mean, s.d.) 3.3 (2.9) 4.3 (9.4) 4.0 (7.7)
Self reported health is poor or fair (%)*** 23.3 45.3 35.8
Reports having tested HIV+ (%) 7.4 5.0 6.1
Reports having tested HCV+ (rather than HCV- or HCV unaware) (%)*** 6.6 56.6 35.0
Does not have health insurance (%) 47.5 36.1 41.0
  1. ** p < .01
  2. *** p < .001